Bopre SRL
Bopre reported total assets of 196,068 € at the end of the 2026 financial year (annual accounts filed with the NBB on 27 Oct 2026).
The score of Bopre shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -37 % Total assets -35 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bopre's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 16,808 € | ||||
| Equity | 99,842 € | ||||
| Cash | 99,557 € | ||||
| EBITDA | 25,096 € | ||||
| Total assets | 196,068 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 27 Oct 2026
- Year ended 31 Mar 2025filed on 14 Nov 2025
- Year ended 31 Mar 2024filed on 28 Oct 2024
- Year ended 31 Mar 2023filed on 30 Nov 2023
- Year ended 31 Mar 2022filed on 29 Nov 2022
Bopre's financial analysis
- Solvency50.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bopre
Bopre's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0430.198.364
- VAT number
- BE0430198364
- Peppol
- Registered · 0208:0430198364 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Dec 1986
- Registered office
- 9300 Aalst
- Latest accounts
- 2026 · filed on 27 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bopre (SRL) has been based in Aalst since 1986, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 16,808 € and equity of 99,842 €; its revenue is not published. Its solvency stands at 50.9%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Bopre
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Bellens Retail sale of pharmaceutical products Lokeren · balance sheet 195,155 €
- Paracelsus Pharma Projects Retail sale of pharmaceutical products Aalter · balance sheet 197,179 €
- Pharmacie de la Molignée Retail sale of pharmaceutical products Mettet · balance sheet 198,726 €
- Heyde Pharma Retail sale of pharmaceutical products Jabbeke · balance sheet 192,810 €
- AC Bizet Retail sale of pharmaceutical products Anderlecht · balance sheet 199,908 €
- Panadem Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet 188,078 €
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Pharmed Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,800 €
Frequently asked questions about Bopre
What is the revenue of Bopre?
Bopre files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Bopre?
In Belgium, the VAT number is the company number prefixed with BE: BE0430198364 for Bopre, if the company is VAT-registered. Its company number (CBE) is 0430.198.364.
Where is the registered office of Bopre?
According to the CBE register, the registered office of Bopre is in 9300 Aalst.
What is the equity of Bopre?
At the close of the 2026 financial year, the equity of Bopre amounts to 99,842 €, a solvency of 50.9% of total assets.
Who manages Bopre?
The register lists 1 active mandates at Bopre. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bopre
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →